India Bharat Biotech’s US Partner Ocugen Files Request with FDA for Covaxin Trials The phase 3 study conducted in India by Ocugen’s business partner, Bharat Biotech, involved 25,798 participants receiving two doses of Covaxin or placebo, 28 days apart. Source: Top India News- News18.com Continue Reading Previous Months Before UP Polls, Agra, Mathura, Aligarh, And Firozabad to Get Free WiFi SpotsNext No Bail For Aryan Khan Yet; Arguments to Continue on Thursday More Stories India Horoscope Today, November 18, 2021: Check Out Daily Astrological Prediction for Aries, Taurus, Libra, Sagittarius And Other Zodiac Signs India Centre Plans First Dose for All by 1st Week of December through ‘Har Ghar Dastak’ Campaign India Kerala Octogenarian Dies in Hospital 6 Weeks After Fatally Hitting Wife